Shanghai today issued a plan to increase the international competitiveness of its biopharmaceutical enterprises, aiming for its medicinal and mechanical products exports to exceed CNY50 billion (USD7 billion) and to have two-three local companies with over CNY10 billion (USD1.4 billion) in overseas sales by 2027.